Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
Paul Langley · INNOVATIONS in Pharmacy · 2021
Abstract onlyNot checked
Decision Sciences: papers
Filters2 filters applied
Topic
Status
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
7 papersQuestions on this topic
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences
Y. Roussel, D. Raoult · New Microbes and New Infections · 2020
Abstract onlyNot checked
Yet another Ersatz World: The ICER Final Evidence Report for Additive Cardiovascular Therapies
Paul Langley · INNOVATIONS in Pharmacy · 2019
Abstract onlyNot checked
The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
Andrea Keyter, Andrea Keyter, Sam Salek et al. · Frontiers in Pharmacology · 2019
Abstract onlyNot checked
Bibliometric and visual analysis of blood-testis barrier research
Yifeng Shen, Yaodong You, Kun Zhu et al. · Frontiers in Pharmacology · 2022
Abstract onlyNot checked
Applying an equity lens to pharmacogenetic research and translation to under‐represented populations
Tiana Luczak, David Stenehjem, Jacob Brown · Clinical and Translational Science · 2021
Abstract onlyNot checked
Prescription pattern of empirical antibiotic therapy in the burn unit of a tertiary care setting in the Kingdom of Saudi Arabia
Khaja Moinuddin, Deemah Sattam Alanazi, Bushra Abdulrahman Alsomali et al. · Journal of Pharmacy and Bioallied Sciences · 2021
Abstract onlyNot checked